Trans-carotid access for TAVR allows safe and rapid exchange for bailout valve-in-valve procedures.
Trans-carotid access for trans-catheter aortic valve replacement is a valid alternative in patients with aortic valve dysfunction, severe peripheral vascular disease, and high-risk for surgery. However, in the event of the need for a bailout valve-in-valve procedure, the safety of this access site is uncertain. We report a patient with aortic regurgitation, previous coronary surgery, peripheral vascular disease, and impaired ventricular function who underwent a CoreValve Evolut-R (Medtronic Inc, Minneapolis, MN) implantation through the left carotid artery followed by a successful valve-in-valve procedure with a 26-mm Edwards Sapien3 valve (Edwards Lifesciences, Irvine, CA) through the same carotid access site.
['Ferrari|Enrico|E|http://orcid.org/0000-0002-2837-3242', 'Caporali|Elena|E|', 'Pedrazzini|Giovanni|G|', 'Demertzis|Stefanos|S|']
D000368:Aged D001021:Aortic Valve D001022:Aortic Valve Insufficiency D002339:Carotid Arteries D002406:Catheterization, Peripheral D004452:Echocardiography D006350:Heart Valve Prosthesis D019918:Heart Valve Prosthesis Implantation D006801:Humans D008297:Male D012306:Risk D025321:Surgery, Computer-Assisted D016896:Treatment Outcome
TAVR aortic valve regurgitation high-risk patients